Immunodeficiencies: injecting some safety into SCID gene therapy?
Candotti
F
F
Roifman
C
C
Puck
J M
JM
D000818:Animals; D015316:Genetic Therapy / Q000009:adverse effects / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D016086:Lentivirus; D051379:Mice; D016511:Severe Combined Immunodeficiency / Q000628:therapy*; D013950:Thymus Gland; D051746:ZAP-70 Protein-Tyrosine Kinase / Q000172:deficiency
D051746:ZAP-70 Protein-Tyrosine Kinase